Amylyx Pharmaceuticals inc. (AMLX) PT Lowered to $4 at Deutsche Bank
Tweet Send to a Friend
Deutsche Bank analyst Neena Bitritto-Garg lowered the price target on Amylyx Pharmaceuticals inc. (NASDAQ: AMLX) to $4.00 (from $8.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
